ABSTRACT NUMBER: ESOC2026A479 SERUM MEPRINΒ PREDICTS EARLY PROGRESSION AND LONG-TERM PROGNOSIS IN ACUTE ISCHEMIC STROKE: A PROSPECTIVE COHORT STUDY
Aipeng Hu, Hailong Yu, Xuetingwen Zhu, Luhang Tao, Jing Hang, Xin Chen, Xiaoyun Huang, Ran Zhang, Li Dong · 2026
Read ABSTRACT NUMBER: ESOC2026A479 SERUM MEPRINΒ PREDICTS EARLY PROGRESSION AND LONG-TERM PROGNOSIS IN ACUTE ISCHEMIC STROKE: A PROSPECTIVE COHORT STUDY by Aipeng Hu, Hailong Yu, Xuetingwen Zhu, Luhang Tao, Jing Hang, Xin Chen, Xiaoyun Huang, Ran Zhang, Li Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145515.txt.
Description
Aipeng Hu and co-authors present a 2026 conference study on a blood protein that may warn of early decline after acute stroke. The protein, called meprinβ, feeds swelling in the brain and weakens the barrier that guards it. The team tested whether blood levels at arrival track later outcomes.
Patients with stroke had higher levels of the protein than people without stroke. Higher levels stood as their own risk sign for early decline and for poor function at three months. Adding the measure to standard risk models sharpened how well they sorted patients. The authors propose the blood test as a handy aid for early risk sorting in stroke care.
Catalog record
| CREATOR | Aipeng Hu, Hailong Yu, Xuetingwen Zhu, Luhang Tao, Jing Hang, Xin Chen, Xiaoyun Huang, Ran Zhang, Li Dong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |